# Characterization and Kinetic of Chemotherapy-induced Cardiovascular Toxicity in Breast Cancer

> **NCT05803889** · — · TERMINATED · sponsor: **Institut de cancérologie Strasbourg Europe** · enrollment: 2 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **OTHER:** Cardiac evaluation
- **OTHER:** Cardiac evaluation

## Key facts

- **NCT ID:** NCT05803889
- **Lead sponsor:** Institut de cancérologie Strasbourg Europe
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2023-09-21
- **Primary completion:** 2024-02-15
- **Final completion:** 2024-02-15
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** The PROTECT-COEUR study had to be stopped primarily due to logistical constraints.
- **Last updated:** 2026-01-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05803889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05803889, "Characterization and Kinetic of Chemotherapy-induced Cardiovascular Toxicity in Breast Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05803889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
